SLGL
Sol Gel Technologies Ltd
NASDAQ: SLGL · HEALTHCARE · BIOTECHNOLOGY
$82.55
-0.63% today
Updated 2026-07-29
Market cap
$271.98M
P/E ratio
—
P/S ratio
14.73x
EPS (TTM)
$-0.32
Dividend yield
—
52W range
$8 – $98
Volume
0.0M
Sol Gel Technologies Ltd (SLGL) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$82.55
12-Month target
—
2030 Target
—
Intrinsic (DCF)
$124.79
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| EPS | — | — | — | — | — |
CAGR applied: — (capped 20%) · P/E: 25.00x (capped 25x) · Margin: -5.66%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.